Ferumoxytol vs. Gadolinium agents for contrast-enhanced MRI: Thoughts on evolving indications, risks, and benefits-Reference-Cited by-同舟云学术

Ferumoxytol vs. Gadolinium agents for contrast-enhanced MRI: Thoughts on evolving indications, risks, and benefits

Published:2017-02-03 Issue:3 Volume:46 Page:919-923
ISSN:1053-1807
Container-title:Journal of Magnetic Resonance Imaging
language:en
Short-container-title:J. Magn. Reson. Imaging

Author:

Finn J. Paul¹²³,Nguyen Kim-Lien²,Hu Peng¹³

Affiliation:

1. Department of Radiological Sciences; UCLA; Los Angeles California USA

2. Medicine, David Geffen School of Medicine, UCLA; Los Angeles California USA

3. Department of Biomedical Physics; UCLA; Los Angeles California USA

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging

Reference50 articles.

1. The use of iron and gadolinium chelates as NMR contrast agents: animal and human studies;Carr;Physiol Chem Phys Med NMR,1984

2. 25 years of contrast-enhanced MRI: developments, current challenges and future perspectives;Lohrke;Adv Ther,2016

3. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis;Kuo;Radiology,2007

4. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure;Deo;Clin J Am Soc Nephrol,2007

5. US Food and Drug Administration Public Health Advisory - Gadolinium-containing Contrast Agents for Magnetic Resonance Imaging (MRI) http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm053112.htm

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferumoxytol-enhanced MR venography for mapping lower-extremity venous networks and evaluating varicose veins in patients with diabetes;European Radiology;2024-05-07

2. Analysis on efficacy of magnetic resonance lymphangiography using INV-001 in healthy beagle dogs;Scientific Reports;2024-05-07

3. Unveiling the next generation of MRI contrast agents: current insights and perspectives on ferumoxytol-enhanced MRI;National Science Review;2024-02-07

4. Comparison of the Pharmacokinetics of Gadolinium-Based and Iron Oxide-Based Contrast Agents inside the Lymphatic Structure using Magnetic Resonance Lymphangiography;2024-01-03

5. Diagnostic Performance and Safety of a Novel Ferumoxytol-Enhanced Coronary Magnetic Resonance Angiography;Circulation: Cardiovascular Imaging;2023-07